Author Question: A patient's platelet count drops 4 days after being placed on heparin. Select the correct ... (Read 102 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
A patient's platelet count drops 4 days after being placed on heparin. Select the correct interpretation.
 
  a. The patient has heparin-induced thrombocytopenia.
  b. The patient has benign, limited thrombocytopenia related to heparin.
  c. A bleeding time should be performed to evaluate qualitative platelet disorders.
  d. An immunoassay for heparin-dependent anti-platelet factor 4 (PF4) should be performed to distinguish heparin-induced thrombocytopenia from benign, limited thrombocytopenia related to heparin.

Question 2

A platelet aggregation study shows diminished response to all agonists except for a small response to arachidonic acid and full response to ristocetin. Which condition is most likely?
 
  a. Glanzmann thrombasthenia
  b. Aspirin use
  c. VWD
  d. Platelet release defect



Anton

  • Sr. Member
  • ****
  • Posts: 302
Answer to Question 1

ANS: D
This pattern, a drop in the platelet count 4 days after being placed on heparin, suggests heparin-induced thrombocytopenia. It could also be a benign, limited thrombocytopenia related to heparin. Assays such as the immunoassay for heparin-dependent anti-PF4 can distinguish the two.

Answer to Question 2

ANS: A
Glanzmann thrombasthenia is diagnosed by its diminished secretion and aggregation responses to all agonists except a modest response to arachidonic acid and full, although nondiagnostic, response to ristocetin.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

For a complete list of videos, visit our video library